Document:

Warrant to Purchase Common Stock (No. CS-05)

 Exhibit 10.14 

THE SECURITIES EVIDENCED BY THIS WARRANT ARE RESTRICTED SECURITIES AND MAY NOT BE SOLD OR OFFERED FOR SALE EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT
OF 1933, AS AMENDED, AND ALL APPLICABLE STATE SECURITIES LAWS. 
  

			
	WARRANT NO. CS-05	 	Date: March 21, 2007

WARRANT TO PURCHASE COMMON STOCK 

AutoGenomics, Inc., a California corporation (the “Company”), hereby certifies that AR Properties is entitled to
purchase, on the terms and conditions contained herein, 150,000 shares (the “Warrant Shares”) of the fully paid, validly issued and nonassessable Common Stock of the Company (the “Common Stock”), at an initial
exercise price of $0.50 per Warrant Share (the “Exercise Price”). The number of Warrant Shares and the Exercise Price are subject to adjustment as provided in Section 2 below. 

This Warrant is subject to the following terms and conditions: 

1. Exercisability and Exercise. 

1.1 Method of Exercise. This Warrant may be exercised in whole at the option of the Holder at any time and from time to time from
the date hereof through and including the fifth (5) year anniversary of the date hereof (the “Exercise Period”), by delivering to the Company payment of the aggregate Exercise Price for the shares being purchased by check or
wire transfer, together with an executed Notice of Exercise in the form attached hereto. 
 1.2 Effectiveness of Exercise;
Procedure. The exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which the Holder delivers the Notice of Exercise to the Company together with payment of the Exercise Price
and satisfies all of the requirements of this Section 1. Upon such exercise, the Holder will be deemed a shareholder of record of the Warrant Shares with all rights of a shareholder (including, without limitation, all voting rights with respect
to such Warrant Shares and all rights to receive any dividends with respect to such Warrant Shares). In the event of any exercise of the rights represented by this Warrant, certificates for the shares of Common Stock so purchased shall be delivered
to the Holder within a reasonable time. The Company shall not be required to issue fractional shares upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Holder shall be entitled, at
its option, to receive either (a) a cash payment equal to the excess of the fair market value, as determined by the Board of Directors of the Company in good faith, for such fractional share above the Exercise Price for such fractional share
(as mutually determined by the Company and the Holder) or (b) a whole share if the Holder tenders the Exercise Price for one whole share. 

2. Adjustments. 

2.1 Reorganizations, Mergers, Recapitalizations and Reclassifications. If, at any time after the date of this Warrant, (i) the
outstanding shares of capital stock issuable upon exercise of this Warrant are changed into, or exchanged for, a different number or kind of shares or securities of the Company through a reorganization, merger, recapitalization or reclassification,
or (ii) the number of outstanding shares of such capital stock is changed 

 
through a stock split, stock dividend, stock consolidation or similar capital adjustment, an appropriate adjustment shall be made by the Board, if necessary, in the Exercise Price and in the
number or kind of shares into which this Warrant is exercisable. In making such adjustments, or in determining that no such adjustments are necessary, the Board may rely upon the advice of counsel and accountants to the Company. 

2.2 Notice of Adjustment. Upon the occurrence of each adjustment or readjustment of the Exercise Price or the number and kind of
securities into which this Warrant is exercisable, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Holder a certificate setting forth such adjustment or
readjustment (including the kind and amount of securities, cash or other property for which this Warrant shall be exercisable and the Exercise Price) and showing in detail the facts upon which such adjustment or readjustment is based. The Company
shall, upon the written request at any time of the Holder, furnish or cause to be furnished to the Holder a certificate setting forth (i) the Exercise Price then in effect and (ii) the number and kind of shares of capital stock and the
amount, if any, of other securities, cash or property which then would be received upon the exercise of this Warrant. 
 3.
Reservation of Stock. The Company shall at all times have authorized, and reserved for the purpose of the issue upon exercise of this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of this Warrant.

 4. Exchange of Warrant. Upon the surrender by the Holder, properly endorsed, to the Company at the principal office of
the Company, the Company will issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of the Holder or as the Holder may direct, without charge for any issuance or
transfer tax or other cost incurred by the Company, calling in the aggregate on the face or faces thereof for the number of shares of capital stock (or other securities, cash and/or property) then issuable upon exercise of this Warrant. The Company
will at no time close its transfer books against the transfer of the Warrant Shares issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this Warrant. 

5. Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the Company, whether
or not the Warrant so lost, stolen, destroyed or mutilated shall be at any time enforceable by anyone. 
 6. Transfer of
Warrant. This Warrant and all rights hereunder are transferable, in whole, upon surrender of this Warrant with a properly executed assignment (in the form of Exhibit II hereto) at the principal office of the Company. 

7. Miscellaneous. 

7.1 Expiration. This Warrant shall expire at the close of business on the date which is five (5) years from the date hereof.

  

 2 

 7.2 Restrictive Legend. This Warrant, any Warrant issued upon transfer of this
Warrant and the shares of Common Stock issued upon exercise of this Warrant shall be imprinted with substantially the following legend, in addition to any legends required under applicable state securities laws: 

“THE SECURITIES EVIDENCED BY THIS WARRANT / CERTIFICATE ARE RESTRICTED SECURITIES AND MAY NOT BE SOLD OR OFFERED FOR SALE EXCEPT IN
COMPLIANCE WITH THE SECURITIES ACT OF 1933, AS AMENDED, AND ALL APPLICABLE STATE SECURITIES LAWS.” 
 7.3 No Voting
Rights. Nothing contained in this Warrant shall be construed as conferring upon Holder by virtue of holding this Warrant (i) the right to vote or to consent as a shareholder in respect of meetings of shareholders for the election of
directors of the Company or any other matter, (ii) the right to receive dividends or (iii) any other rights as a shareholder of the Company. 

7.4 Compliance with Securities Laws. Holder agrees to exercise this Warrant in compliance with all applicable federal and state
securities laws and agrees to cooperate with the Company in taking any and all action which may be deemed necessary or desirable to ensure such compliance, including, without limitation, the execution and delivery of one or more documents as
requested by the Company representing as to certain matters and acknowledging the restricted nature of the Common Stock to be issued. 

7.5 Modification And Waiver. This Warrant and any provision hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement is sought. 
 7.6 Saturdays, Sundays, Holidays, etc.
If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next
succeeding day not a Saturday or a Sunday or a legal holiday. 
 7.7 Successors and Assigns. This Warrant shall be
binding upon any successors or assigns of the Company. 
  

 3 

 [ Signature Page to Warrant to Purchase Common Stock ] 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed and issued by its duly authorized representative on the date first
above written. 
  

			
	AUTOGENOMICS, INC.
		
	By:	 	 /s/ Fareed Kureshy

		 	Fareed Kureshy,
		 	Its President and CEO

  

 4 

 EXHIBIT I 

FORM OF NOTICE OF EXERCISE 

(To be signed only upon exercise of this Warrant) 

The undersigned, the Holder of the within Warrant, hereby irrevocably elects to exercise such Warrant to purchase
                                        
(                    ) shares of the Company’s Common Stock for a purchase price of
                                        
Dollars ($            ) per share and a total purchase price of
                                        
Dollars ($            ), to be paid by (check one): 

             certified or official bank check; or 

             wire transfer. 

The undersigned is acquiring such shares of stock for its own account for investment purposes only and not with a view to or for sale in
connection with any distribution thereof. 
  

			
	Dated:                     	 	  

		 	 Name of Holder (must conform precisely

to the name specified on the face of the Warrant)

		
		 	  

		 	Signature of authorized representative of Holder
		
		 	  

		 	Print or type name of authorized representative
		
	Federal Identification Number of Holder:	 	  

		
	Address of Holder:	 	  

		
		 	  

		
	Telephone Number:	 	  

		
	Facsimile Number:	 	  

		
	Email Address:	 	  

	  

	  

 

 5 

 EXHIBIT II 

ASSIGNMENT FORM 
 FOR VALUE
RECEIVED,
                                         
                    hereby sells, assigns and transfers all of the rights of the undersigned under the attached Warrant with respect to the number and
kind of shares covered thereby set forth below, unto: 
  

			
	Name of Assignee:	 	  

		
	Address:	 	  

		
		 	  

		
	Telephone Number:	 	  

		
	Facsimile Number:	 	  

		
	Email Address:	 	  

		
	Number and Kind of Shares:	 	  

		
		 	  

 

					
	 Dated:                     
	 	*Signature:	 	  

 

	*	The signature should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an
approved signature guarantee medallion program) pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934. 

  

			
	Signature Guaranteed: Title of Organization:	 	  

		
		 	  

		
	Dated:                      By:	 	  

		
	Name of Authorized Signatory:	 	  

		
	Title of Authorized Signatory:	 	  

  

 6 

 Schedule to Exhibit 10.14 

The following common stock warrants are substantially identical in all material respects to the representative warrant to which this
schedule is attached and which is filed as an exhibit to AutoGenomics, Inc.’s registration statement on Form S-1 (Reg. No. 333-152512) (the “Registration Statement”), except as to the parties thereto, dates of issuance, number of
warrant shares, exercise prices, vesting periods and expiration dates set forth below. These other common stock warrants are not being filed with the Registration Statement, pursuant to Instruction 2 to Item 601 of Regulation S-K promulgated
under the Securities Exchange Act of 1934, as amended. 
  

														
	 Number
	  	 Holder
	  	 Date of Issuance
	  	Warrant Shares	  	Exercise Price
(per share)	  	 Vesting Period
	  	Expiration Date
	CS-06	  	GenoMatrix India	  	May 5, 2008	  	50,000	  	$	0.60	  	50% at grant, 50% one year from grant	  	May 6, 2013
	CS-07	  	Dennis Repp	  	January 15, 2010	  	100,000	  	$	2.74	  	Fully vested at grant	  	January 16, 2015Warrant to Purchase Common Stock (No. 200809-010)

 Exhibit 10.15 

THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR UNDER ANY APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES
LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS. 

 

			
	WARRANT NO. 200809-010 (Amended)	  	Date: September 25, 2008

WARRANT TO PURCHASE COMMON STOCK 

AutoGenomics, Inc., a Delaware corporation (the “Company”), hereby certifies that William Davidson (the
“Holder”), is entitled to purchase, on the terms and conditions contained herein, 28,400 fully paid, validly issued and nonassessable shares (the “Warrant Shares”) of common stock, no par value, of the Company (the
“Common Stock”), at an initial exercise price of $7.00 per Warrant Share (the “Exercise Price”). This Warrant has been approved by the Board of Directors of the Company and is issued pursuant to the terms of that
certain Subscription Agreement, dated as of the date hereof, by and between the Company and the Holder (the “Subscription Agreement”). The number of Warrant Shares and the Exercise Price are subject to adjustment as provided in
Section 2 below. 
 This Warrant is subject to the following terms and conditions: 

1. Exercisability and Exercise. 

1.1 Method of Exercise. This Warrant may be exercised in whole at the option of the Holder at any time and from time to time from
the one (1) year anniversary of the date hereof through and including the five (5) year anniversary of the date hereof (the “Exercise Period”), by delivering to the Company payment of the aggregate Exercise Price for the
Warrant Shares being purchased by check or wire transfer, together with an executed Notice of Exercise in the form attached as Exhibit I hereto. 

1.2 Effectiveness of Exercise; Procedure. The exercise of this Warrant shall be deemed to have been effected immediately prior to
the close of business on the day on which the Holder delivers the Notice of Exercise to the Company together with payment of the Exercise Price and satisfies all of the requirements of this Section 1. Upon such exercise, the Holder will be
deemed a shareholder of record of the Warrant Shares with all rights of a shareholder (including, without limitation, all voting rights with respect to such Warrant Shares and all rights to receive any dividends with respect to such Warrant Shares).
In the event of any exercise of the rights represented by this Warrant, certificates for the shares of Common Stock so purchased shall be delivered to 

 

 Page 1 

 
the Holder within a reasonable time by the transfer agent of the Company by crediting the account of the Holder’s broker with The Depositary Trust Company through its Deposit Withdrawal
Agent Commission system if the Company is a participant in such system, and otherwise by physical delivery to the address specified in the Notice of Exercise. The Company shall not be required to issue fractional shares upon the exercise of this
Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Holder shall be entitled, at its option, to receive either (a) a cash payment equal to the excess of the fair market value, as determined by the Board
of Directors of the Company in good faith, for such fractional share above the Exercise Price for such fractional share (as mutually determined by the Company and the Holder) or (b) a whole share if the Holder tenders the Exercise Price for one
whole share. 
 2. Adjustments. 

2.1 Reorganizations, Mergers, Recapitalizations and Reclassifications. 

(a) Change of Control. If at any time a Change of Control (as defined below) occurs and, pursuant to the terms of such Change of
Control, shares of common stock of the successor or acquiring corporation, or any cash, shares of stock or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition to or in lieu
of common stock of the successor or acquiring corporation (“Other Property”), are to be received by or distributed to the holders of Common Stock of the Company, then the Holder shall have the right thereafter to receive upon
exercise of this Warrant (and this Warrant shall thereafter be exercisable only for) the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and Other Property receivable
upon or as a result of such Change of Control by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Change of Control. In case of any such Change of Control, the successor or acquiring
corporation (if other than the Company) shall expressly assume the due and punctual observance and performance of each and every covenant and condition of this Warrant to be performed and observed by the Company and all the obligations and
liabilities hereunder, subject to such modifications as may be deemed appropriate (as determined in good faith by resolution of the Board of Directors of the Company) in order to provide for adjustments of the Warrant Shares for which this Warrant
is exercisable which shall be as nearly equivalent as practicable to the adjustments provided for in this Section 2.1(a). For purposes of this Section 2.1(a), “common stock of the successor or acquiring corporation” shall include
stock of such corporation of any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject to redemption. The foregoing provisions of this Section 2.1(a) shall similarly
apply to any successive Change of Control. As used in this Warrant, a “Change of Control” shall mean (i) a transaction or series of transactions (other than an offering of common stock of the Company to the general public
through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Securities Exchange
Act of 1934, as amended from time to time (the “Exchange Act”)) (other than the Company, any of its subsidiaries, an employee benefit plan maintained by 

 

 Page 2 

 
the Company or any of its subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company)
directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding
immediately after such acquisition; or (ii) the consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (A) a merger, consolidation, reorganization or
business combination, (B) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (C) the acquisition of assets or stock of another entity, in each
case other than a transaction (1) which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the
Successor Entity (as defined below)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and (2) after which no person or group
beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this Section 2.1(a)(ii)(C)(2) as
beneficially owning 50% or more of combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction. As used in this Section 2.1(a)(ii)(C), the
“Successor Entity” shall mean, as applicable, the Company or the person that, as a result of the Change of Control, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the
Company’s assets or otherwise succeeds to the business of the Company. 
 (b) Other Events. If, at any time after
the date of this Warrant, (i) the outstanding shares of Common Stock issuable upon exercise of this Warrant are changed into, or exchanged for, a different number or kind of shares or securities of the Company through a reorganization, merger,
recapitalization or reclassification which does not constitute a Change of Control, or (ii) the number of outstanding shares of such Common Stock is changed through a stock split, reverse stock split, stock dividend, stock consolidation or
similar capital adjustment, an appropriate adjustment shall be made by the Board, if necessary, in the Exercise Price and in the number or kind of shares into which this Warrant is exercisable. In making such adjustments, or in determining that no
such adjustments are necessary, the Board may rely upon the advice of counsel and accountants to the Company. 
 2.2 Notice
of Adjustment. Upon the occurrence of each adjustment or readjustment of the Exercise Price or the number and kind of securities into which this Warrant is exercisable, the Company at its expense shall promptly compute such adjustment or
readjustment in accordance with the terms hereof and furnish to the Holder a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property for which this Warrant shall be exercisable
and the Exercise Price) and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of the Holder, furnish or cause to be furnished to the Holder a certificate setting
forth (i) the 
  

 Page 3 

 
Exercise Price then in effect and (ii) the number and kind of shares of capital stock and the amount, if any, of other securities, cash or property which then would be received upon the
exercise of this Warrant. 
 3. Reservation of Stock. The Company shall at all times have authorized, and reserved for
the purpose of the issue upon exercise of this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of this Warrant. 

4. Notices of Record Date, etc. In the event the Company shall take a record of the holders of any of its Common Stock for the
purpose (a) of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right; (b) of
any capital reorganization of the Company, any reclassification of the stock of the Company or any Change of Control; or (c) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company; then, and in each such case, the
Company will mail or cause to be mailed to the Holder a notice specifying, as the case may be, (x) the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (y) the
effective date on which such reorganization, reclassification, consolidation, Change of Control, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock of the
Company shall be entitled to exchange their shares for securities or other property deliverable upon such reorganization, reclassification, consolidation, Change of Control, dissolution, liquidation or winding-up. Such notice shall be mailed at
least ten days prior to the record date or effective date for the event specified in such notice. 
 5. Exchange of
Warrant. Upon the surrender by the Holder, properly endorsed, to the Company at the principal office of the Company, the Company will issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants
of like tenor, in the name of the Holder or as the Holder may direct, without charge for any issuance or transfer tax or other cost incurred by the Company, calling in the aggregate on the face or faces thereof for the number of shares of capital
stock (or other securities, cash and/or property) then issuable upon exercise of this Warrant. The Company will at no time close its transfer books against the transfer of the Warrant Shares issued or issuable upon the exercise of this Warrant in
any manner which interferes with the timely exercise of this Warrant. 
 6. Replacement of Warrant. Upon receipt of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount
reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. Any such new Warrant executed and delivered shall
constitute an additional contractual obligation on the part of the Company, whether or not the Warrant so lost, stolen, destroyed or mutilated shall be at any time enforceable by anyone. 

 

 Page 4 

 7. Transfer of Warrant. This Warrant and all rights hereunder are transferable, in
whole, upon surrender of this Warrant with a properly executed assignment (in the form of Exhibit II hereto) at the principal office of the Company. However, as a condition to such transfer, either (a) this Warrant must be registered
under the Securities Act of 1933, as amended (the “Act”), and all applicable state securities laws with respect thereto or (b) the Company must first be furnished with an opinion of legal counsel, reasonably satisfactory to the
Company, to the effect that such transfer is exempt from the registration requirements of the Act. 
 8. Miscellaneous.

 8.1 Expiration. This Warrant shall expire at the close of business on the date which is four (4) years from the
date hereof. 
 8.2 Restrictive Legend. This Warrant, any Warrant issued upon transfer of this Warrant and the shares of
Common Stock issued upon exercise of this Warrant shall be imprinted with substantially the following legend, in addition to any legends required under applicable state securities laws: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR
UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL
APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS.” 

8.3 No Voting Rights. Nothing contained in this Warrant shall be construed as conferring upon Holder by virtue of holding this
Warrant (i) the right to vote or to consent as a shareholder in respect of meetings of shareholders for the election of directors of the Company or any other matter, (ii) the right to receive dividends or (iii) any other rights as a
shareholder of the Company. 
 8.4 Compliance with Securities Laws. Holder agrees to exercise and transfer (to the extent
permitted pursuant to Section 7 hereof) this Warrant in compliance with all applicable federal and state securities laws and agrees to cooperate with the Company in taking any and all action which may be deemed necessary or desirable to ensure
such compliance, including, without limitation, the execution and delivery of one or more documents as requested by the Company representing as to certain matters and acknowledging the restricted nature of the Common Stock to be issued. 

 

 Page 5 

 8.5 Modification And Waiver. This Warrant and any provision hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement is sought. 

8.6 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday or a Sunday or a legal holiday. 

8.7 Successors and Assigns. This Warrant shall be binding upon any successors or assigns of the Company. 

8.8 Notices. All notices, requests, consents and demands with respect to this Warrant shall be made in writing and shall be deemed
effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five days after
having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All
communications shall be sent to the Company at 2251 Rutherford Road, Carlsbad, CA 92008, and to Holder at the applicable address set forth on the applicable signature page to the Subscription Agreement or at such other address as the Company or
Holder may designate by ten (10) days advance written notice to the other parties hereto. 
 8.9 Governing Law. This
Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the jurisdiction of incorporation of the Company, without regard to its principles of choice of law. 

 

 Page 6 

 [ Signature Page to Warrant to Purchase Common Stock ] 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed and issued by its duly authorized representative on the date first
above written. 
  

			
	AUTOGENOMICS, INC.
		
	By:	 	 /s/ Fareed Kureshy

		 	Fareed Kureshy,
		 	Its President and CEO

  

 Page 7 

 EXHIBIT I 

FORM OF NOTICE OF EXERCISE 

(To be signed only upon exercise of this Warrant) 

The undersigned, the Holder of the within Warrant, hereby irrevocably elects to exercise such Warrant to purchase
                                         
                    (                    )
shares of the Company’s common stock, no par value, for a purchase price of
                                        
Dollars ($                    ) per share and a total purchase price of
                                        
Dollars ($                    ), to be paid by (check one): 

             certified or official bank check; or

              wire transfer. 

The undersigned is acquiring such shares of stock for its own account for investment purposes only and not with a view to or for sale in
connection with any distribution thereof. 
  

			
	 Dated:
                                        

	 	  

		 	 Name of Holder (must conform precisely

to the name specified on the face of the Warrant)

		
		 	  

		 	Signature of authorized representative of Holder
		
		 	  

		 	Print or type name of authorized representative
		
	Federal Identification Number of Holder:	 	  

		
	Address of Holder:	 	  

		
		 	  

		
	Telephone Number:	 	  

		
	Facsimile Number:	 	  

		
	Email Address:	 	  

 

 Page 8 

 EXHIBIT II 

ASSIGNMENT FORM 
 FOR VALUE
RECEIVED,
                                         
                                        hereby
sells, assigns and transfers all of the rights of the undersigned under the attached Warrant with respect to the number and kind of shares covered thereby set forth below, unto: 

 

					
	Name of Assignee:	  	  

		
	Address:	  	  

		
		  	  

		
	Telephone Number:	  	  

		
	Facsimile Number:	  	  

		
	Email Address:	  	  

		
	Number and Kind of Shares:	  	  

		
		  	  

			
	Dated:
                                        
	 	*Signature:	  	  

  

	*	The signature should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an
approved signature guarantee medallion program) pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934. 

  

					
	Signature Guaranteed: Title of Organization:	 		  	
	  
	 		  	
			
		 		  	  

			
	 Dated:
                                        

	 	By:	  	  

		
	Name of Authorized Signatory:	  	  

		
	Title of Authorized Signatory:	  	  

  

 Page 9 

 Schedule to Exhibit 10.15 

The following common stock warrants are substantially identical in all material respects to the representative warrant to which this
schedule is attached and which is filed as an exhibit to AutoGenomics, Inc.’s registration statement on Form S-1 (Reg. No. 333-152512) (the “Registration Statement”), except as to the parties thereto, dates of issuance, number of
warrant shares, exercise prices and expiration dates set forth below. These other common stock warrants are not being filed with the Registration Statement, pursuant to Instruction 2 to Item 601 of Regulation S-K promulgated under the
Securities Exchange Act of 1934, as amended. 
  

												
	 Number
	  	 Holder
	  	 Date of Issuance
	  	Warrant Shares	  	Exercise Price
(per share)	  	 Expiration Date

	200903-007	  	National Healthcare Services	  	March 30, 2009	  	142,000	  	$	7.00	  	October 20, 2012
	200906-020	  	National Healthcare Services	  	June 26, 2009	  	142,000	  	$	7.00	  	October 20, 2012
	200912-001	  	National Healthcare Services	  	December 8, 2009	  	142,000	  	$	4.00	  	December 8, 2014
	200912-003	  	AR Properties	  	December 1, 2009	  	26,980	  	$	4.00	  	December 1, 2014
	200912-005	  	Shugart Corporation	  	December 31, 2009	  	142,000	  	$	4.00	  	December 31, 2014
	201002-001	  	AR Properties	  	February 9, 2010	  	28,400	  	$	4.00	  	February 11, 2015
	201002-002	  	Piercey Living Trust	  	February 12, 2010	  	71,000	  	$	4.00	  	February 11, 2015
	201002-003	  	R&M AutoGenomics Investors	  	February 16, 2010	  	14,200	  	$	4.00	  	February 15, 2015
	201002-004	  	J Piercey Trust	  	February 18, 2010	  	28,400	  	$	4.00	  	February 17, 2015
	201003-000	  	The Meyyapan – Kannappan Family Trust	  	March 2, 2010	  	7,100	  	$	4.00	  	March 1, 2015
	201004-001	  	Robert A. Levin and Mary B. Levin, Trustees of The Levin Family Recovable Trust	  	April 15, 2010	  	42,600	  	$	5.00	  	March 3, 2015
	201004-002	  	Heiligbrodt Family Partnership	  	April 15, 2010	  	142,000	  	$	5.00	  	March 4, 2015
	201004-003	  	Kentor Trust U/A dated 9/18/2002	  	April 15, 2010	  	71,000	  	$	5.00	  	March 8, 2015
	201004-004	  	God’s Gift	  	April 15, 2010	  	142,000	  	$	5.00	  	March 11, 2015
	201004-005	  	Belmont Insurance Company	  	April 15, 2010	  	28,400	  	$	5.00	  	March 16, 2015
	201004-006	  	Argus Reinsurance, Ltd	  	April 15, 2010	  	71,000	  	$	5.00	  	March 19, 2015
	201004-007	  	Strader Family Trust dated April 25, 2005	  	April 15, 2010	  	28,400	  	$	5.00	  	March 25, 2015

												
	201004-008	  	Bubalo Family Trust	  	April 15, 2010	  	28,400	  	$	5.00	  	April 19, 2015
	201004-009	  	Testman Trust	  	April 15, 2010	  	14,200	  	$	5.00	  	August 30, 2015
	201004-010	  	Terence A. Noonan	  	April 15, 2010	  	7,100	  	$	5.00	  	September 7, 2015
	201004-011	  	Laurence M. Demers	  	April 15, 2010	  	14,200	  	$	5.00	  	September 6, 2015
	201004-012	  	Zurlo Investment Trust	  	April 15, 2010	  	14,200	  	$	5.00	  	September 12, 2015
	201004-013	  	Kentor Trust U/A dated 9/18/2002	  	April 15, 2010	  	14,200	  	$	5.00	  	September 20, 2015
	201004-014	  	Linda Formo Brandes Revocable Trust	  	April 15, 2010	  	71,000	  	$	5.00	  	September 27, 2015
	201004-015	  	AR Properties	  	April 15, 2010	  	284,000	  	$	5.00	  	September 28, 2015
	201004-016	  	Helen Lovaas 2006 Irrevocable Trust FBO Theresa Bell	  	April 15, 2010	  	14,200	  	$	5.00	  	September 30, 2015
	201004-017	  	Helen Lovaas 2006 Irrevocable Trust FBO Cindy Westwood	  	April 15, 2010	  	14,200	  	$	5.00	  	September 30, 2015
	201004-018	  	Helen Lovaas 2006 Irrevocable Trust FBO Kathy Redenius	  	April 15, 2010	  	14,200	  	$	5.00	  	September 30, 2015
	201004-019	  	Helen Lovaas 2006 Irrevocable Trust FBO Daniel Lovaas	  	April 15, 2010	  	14,200	  	$	5.00	  	September 30, 2015
	201004-020	  	Helen Lovaas 2006 Irrevocable Trust FBO Frank Bartlett	  	April 15, 2010	  	14,200	  	$	5.00	  	September 30, 2015
	201004-021	  	Helen Lovaas 2006 Irrevocable Trust FBO Christine Fennel	  	April 15, 2010	  	14,200	  	$	5.00	  	September 30, 2015
	201004-022	  	Ulrich Frindt Family Trust U/T/A dated October 21, 2002	  	April 15, 2010	  	14,200	  	$	5.00	  	October 4, 2015
	201004-023	  	Jason Livingston and Paula Livingston Community Property	  	April 15, 2010	  	28,400	  	$	5.00	  	October 8, 2015

											
	201004-024	  	R&E Lunn Revocable Trust dated March 10, 2004	  	April 15, 2010	  	14,200	  	$5.00	  	October 13, 2015
	201004-025	  	Levin Family Revocable Trust dated February 22, 2007	  	April 15, 2010	  	28,400	  	$5.00	  	October 29, 2015
	201004-026	  	Rue Family Trust	  	April 15, 2010	  	71,000	  	$5.00	  	February 14, 2016
	201004-027	  	IAS Management, LLC	  	April 15, 2010	  	71,000	  	$5.00	  	February 16, 2016
	201004-028	  	Cyndy Reinking	  	April 15, 2010	  	71,000	  	$5.00	  	May 1, 2016
	201004-029	  	Joseph P. Sullivan	  	April 15, 2010	  	2,840	  	$5.00	  	June 20, 2016
	201004-030	  	Harold F. McGrath Trustee of the McGrath Family Trust	  	April 15, 2010	  	42,600	  	$5.00	  	March 11, 2015
	201004-031	  	Van Fleet Family Trust	  	April 15, 2010	  	14,200	  	$5.00	  	October 8, 2015
	201004-032	  	National Healthcare Services	  	April 15, 2010	  	284,000	  	$5.00	  	March 9, 2015
	201004-033	  	The Testman Trust	  	April 15, 2010	  	15,620	  	$5.00	  	March 9, 2015

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]